Search

Jennifer A Inghrim

from Branchburg, NJ
Age ~45
Get Report
Also known as:
Jenny A Inghrim
Related to:
Bryan T Donnell, 44Catherine M Inghrim, 55William J Donnell, 72Mildred W Donnell, 73Edward R Inghrim, 82Craig W Inghrim, 56Ellen L Inghrim, 76Stephen E Inghrim, 58Dorothy R Inghrim, 80Andrew F Donnell, 46
Connected to:
Steven M Ingino, 48Deanna L Ingison, 52Jane M Ingison, 64Kristen E Ingison, 36Melanie A Ingland, 40Alana Ingle, 68Alex A Ingle, 60Alexandra Ingle, 33Annie M Ingle, 79Ashish A Ingle, 37

Jennifer Inghrim Phones & Addresses

  • Branchburg, NJ
  • Belle Mead, NJ
  • Plainsboro, NJ
  • Hellertown, PA
  • 245 Naughright Rd, Long Valley, NJ 07853 (908) 876-0079
  • Belvidere, NJ
  • New York, NY
  • Piscataway, NJ
  • 245 Naughright Rd, Long Valley, NJ 07853 (908) 461-0277

Work

Position: Private Household Service Occupations

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jennifer Inghrim
Systems Staff
Atrion Communication Resources, Inc
Whol Electronic Parts/Equipment
185 Industrial Pkwy, Millstone, NJ 08876
(908) 231-7777

Publications

Us Patents

3-Amino Chroman And 2-Amino Tetralin Derivatives

View page
US Patent:
20050032873, Feb 10, 2005
Filed:
Jul 26, 2004
Appl. No.:
10/898866
Inventors:
Nicole Hatzenbuhler - Bridgewater NJ, US
Deborah Evrard - Hamilton Square NJ, US
Richard Mewshaw - King of Prussia PA, US
Dahui Zhou - East Brunswick NJ, US
Uresh Shah - Cranbury NJ, US
Jennifer Inghrim - Hellertown PA, US
Steven Lenicek - Plainsboro NJ, US
Reinhardt Baudy - Buckingham PA, US
John Butera - Clarksburg NJ, US
Annmarie Sabb - Pennington NJ, US
Amedeo Failli - Princeton Junction NJ, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K031/405
A61K031/381
A61K031/353
C07D049/02
C07D045/02
US Classification:
514414000, 514443000, 514456000, 514469000, 548454000, 549403000, 549049000
Abstract:
3-Amino chroman and 2-amino tetralin derivatives and compositions containing such compounds are disclosed. Methods of using the 3-amino chroman and 2-amino tetralin compounds and compositions containing such compounds in the treatment of serotonin disorders, such as depression and anxiety, are also disclosed.

Jak2 Inhibitors And Their Use For The Treatment Of Myeloproliferative Diseases And Cancer

View page
US Patent:
20110059943, Mar 10, 2011
Filed:
Sep 2, 2010
Appl. No.:
12/874276
Inventors:
Ashok V. Purandare - Pennington NJ, US
James W. Grebinski - Lawrenceville NJ, US
Amy Hart - Ewing NJ, US
Jennifer Inghrim - Plainsboro NJ, US
Gretchen Schroeder - Ewing NJ, US
Honghe Wan - Pennington NJ, US
International Classification:
A61K 31/437
C07D 471/14
A61K 31/5377
C07D 519/00
A61K 31/496
A61K 31/541
A61P 35/00
US Classification:
51421018, 546 82, 514293, 544126, 5142328, 544361, 51425303, 544 582, 5142285
Abstract:
The present invention provides compounds of formula Iand pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of JAK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.

Jak2 Inhibitors And Their Use For The Treatment Of Myeloproliferative Diseases And Cancer

View page
US Patent:
20130225551, Aug 29, 2013
Filed:
Apr 30, 2012
Appl. No.:
13/459742
Inventors:
Ashok V. Purandare - Pennington NJ, US
James W. Grebinski - Lawrenceville NJ, US
Amy Hart - Ewing NJ, US
Jennifer Inghrim - Plainsboro NJ, US
Gretchen Schroeder - Ewing NJ, US
Honghe Wan - Pennington NJ, US
International Classification:
A61K 31/437
A61K 31/5377
A61K 45/06
A61K 31/496
A61K 31/541
C07D 471/14
C07D 513/04
US Classification:
51421018, 514293, 5142328, 51425303, 51421021, 5142285
Abstract:
The present invention provides compounds of formula Iand pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of JAK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.

Imidazotriazinecarbonitriles Useful As Kinase Inhibitors

View page
US Patent:
20140018319, Jan 16, 2014
Filed:
Jul 12, 2013
Appl. No.:
13/940619
Inventors:
Brian E. Fink - Yardley PA, US
Ashvinikumar V. Gavai - Princeton Junction NJ, US
Walter Lewis Johnson - Waterbury CT, US
Amy C. Hart - Ewing NJ, US
Liqi He - Furlong PA, US
Tram N. Huynh - Pennington NJ, US
Jennifer Inghrim - Plainsboro NJ, US
Harold Mastalerz - Guildford CT, US
Xiaopeng Sang - Glastonbury CT, US
Christine M. Tarby - Lawrenceville NJ, US
Honghe Wan - Pennington NJ, US
Wayne Vaccaro - Yardley PA, US
Guifen Zhang - Wallingford CT, US
Yufen Zhao - Pennington NJ, US
Kurt Zimmermann - Durham CT, US
International Classification:
A61K 31/675
A61K 31/53
A61K 31/551
A61K 31/5377
C07D 487/10
C07F 9/6521
C07D 498/04
A61K 31/5383
A61K 45/06
C07D 487/04
C07D 471/10
US Classification:
514 81, 544184, 514243, 540575, 544112, 5142332, 51421021, 51421002, 51421018, 5142325, 544 81, 544105, 5142305
Abstract:
The invention provides compounds of Formula (I)and pharmaceutically acceptable salts thereof. The Formula (I) imidazotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.

Ido Inhibitors

View page
US Patent:
20160137595, May 19, 2016
Filed:
Jul 1, 2014
Appl. No.:
14/897668
Inventors:
- Princeton NJ, US
Steven P. Seitz - Swarthmore PA, US
James Aaron Balog - Lambertville NJ, US
Audris Huang - New Hope PA, US
Sunil Kumar Mandal - Bangalore, Karnataka, IN
David K. William - Delran NJ, US
Amy C. Hart - Ewing NJ, US
Jennifer Inghrim - Plainsboro NJ, US
International Classification:
C07C 275/42
C07D 213/79
C07D 257/04
C07C 311/51
C07C 311/09
C07D 307/79
A61K 45/06
A61K 31/196
A61K 31/4418
A61K 31/444
A61K 31/41
A61K 31/18
A61K 31/343
A61K 31/277
C07D 213/75
Abstract:
There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine 2,3-di-oxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

Imidazotriazinecarbonitriles Useful As Kinase Inhibitors

View page
US Patent:
20150210697, Jul 30, 2015
Filed:
Jul 12, 2013
Appl. No.:
14/414152
Inventors:
- Princeton NJ, US
Brian E. Fink - Yardley PA, US
Walter Lewis Johnson - Waterbury CT, US
Amy C. Hart - Ewing NJ, US
Liqi He - Furlong PA, US
Tram N. Huynh - Pennington NJ, US
Jennifer Inghrim - Plainsboro NJ, US
Harold Mastalerz - Guilford CT, US
Xiaopeng Sang - Glastonbury CT, US
Christine M. Tarby - Lawrenceville NJ, US
Honghe Wan - Pennington NJ, US
Wayne Vaccaro - Yardley PA, US
Guifen Zhang - Wallingford CT, US
Yufen Zhao - Pennington NJ, US
Kurt Zimmermann - Durham CT, US
Yong Zhang - Princeton Junction NJ, US
Libing Chen - Newtown PA, US
Bin Chen - Pennington NJ, US
John S. Tokarski - Princeton NJ, US
Ashvinikumar V. Gavai - Princeton Junction NJ, US
International Classification:
C07D 487/04
C07F 7/18
C07D 487/10
C07D 487/08
C07D 471/10
Abstract:
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.

Imidazotriazinecarbonitriles Useful As Kinase Inhibitors

View page
US Patent:
20150065465, Mar 5, 2015
Filed:
Nov 4, 2014
Appl. No.:
14/532218
Inventors:
- Princeton NJ, US
Brian E. Fink - Yardley PA, US
Ashvinikumar V. Gavai - Princeton Junction NJ, US
Walter Lewis Johnson - Waterbury CT, US
Amy C. Hart - Ewing NJ, US
Liqi He - Furlong PA, US
Tram N. Huynh - Pennington NJ, US
Jennifer Inghrim - Plainsboro NJ, US
Harold Mastalerz - Guiford CT, US
Xiaopeng Sang - Glastonbury CT, US
Christine M. Tarby - Lawrenceville NJ, US
Honghe Wan - Pennington NJ, US
Wayne Vaccaro - Yardley PA, US
Guifen Zhang - Wallingford CT, US
Yufen Zhao - Pennington NJ, US
Kurt Zimmermann - Durham CT, US
International Classification:
C07D 487/04
A61K 45/06
A61K 31/541
C07D 487/08
A61K 31/5383
C07D 519/00
A61K 31/55
A61K 31/5377
C07F 9/6561
A61K 31/675
A61K 31/53
A61K 31/551
US Classification:
514 81, 544184, 514243, 544 582, 5142285, 540556, 514221, 51421016, 540575, 51421021, 544112, 5142332, 51421018, 544105, 5142305
Abstract:
The invention provides compounds of Formula (I)and pharmaceutically acceptable salts thereof. The Formula (I) imidazotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.
Control profile
Jennifer A Inghrim from Branchburg, NJ, age ~45 Get Report